SSPG titer is a diagnostic marker for adrenocortical adenoma in patients with non-functioning adrenal incidentaloma

被引:5
作者
Hashimoto, S [1 ]
Midorikawa, S [1 ]
Sanada, H [1 ]
Watanabe, T [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 3, Fukushima 9601295, Japan
关键词
adrenocortical incidentaloma; insulin resistance; non-functioning tumor;
D O I
10.1016/S0753-3322(00)80038-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We analyzed insulin resistance-related clinical markers as well as imaging characteristics of adrenal masses in 11 patients with incidentally discovered adrenal tumors that were diagnosed as non-functioning according to the results of the 1 mg dexamethasone suppression test and then voluntarily resected. Histologic examination of the resected tumors revealed adrenocortical adenoma in eight patients, and non-cortical tumors: a myelolipoma, an endothelioma and an adrenal vascular cyst in three patients. All eight patients with adrenocortical adenoma exhibited insulin resistance as estimated by the steady state plasma glucose (SSPG). The mean systolic blood pressure of the patients with adrenocortical adenoma was higher than that of the patients with non-cortical tumors; even though three of eight patients were normotensive. HOMA-R, Sigma IRI on 75 g oGTT, diastolic blood pressure and serum triglyceride were not significantly different between the patients with adrenocortical adenomas and those with non-cortical tumors. Imaging characteristic such as tumor size, shape and heterogenity in the mass did not distinguish these two groups either. These results suggest that the presence of insulin resistance estimated by SSPG may be a diagnostic marker for adrenocortical adenoma in patients with a non-functioning incidentaloma. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:175S / 177S
页数:3
相关论文
共 12 条
[1]   The clinical evaluation of silent adrenal masses [J].
Ambrosi, B ;
Passini, E ;
Re, T ;
Barbetta, L .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (02) :90-107
[2]   Adrenocortical tumors: Recent advances in basic concepts and clinical management [J].
Bornstein, SR ;
Stratakis, CA ;
Chrousos, GP .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (09) :759-771
[3]   Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure [J].
Colao, A ;
Pivonello, R ;
Spiezia, S ;
Faggiano, A ;
Ferone, D ;
Filippella, M ;
Marzullo, P ;
Cerbone, G ;
Siciliani, M ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2664-2672
[4]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[5]  
HERR HW, 1991, EUR UROL, V19, P1
[6]   Modified method using a somatostatin analogue, octreotide acetate (Sandostatin(R)) to assess in vivo insulin sensitivity [J].
Ikebuchi, M ;
Suzuki, M ;
Kageyama, A ;
Hirose, J ;
Yokota, C ;
Ikeda, K ;
Shinozaki, K ;
Todo, R ;
Harano, Y .
ENDOCRINE JOURNAL, 1996, 43 (01) :125-130
[7]  
KATO K, 2000, IN PRESS METABOLISM
[8]   Extensive personal, experience - Adrenocortical tumors [J].
Latronico, AC ;
Chrousos, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1317-1324
[9]   ENDOCRINE EVALUATION OF INCIDENTALLY DISCOVERED ADRENAL MASSES (INCIDENTALOMAS) [J].
OSELLA, G ;
TERZOLO, M ;
BORRETTA, G ;
MAGRO, G ;
ALI, A ;
PIOVESAN, A ;
PACCOTTI, P ;
ANGELI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1532-1539
[10]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607